# A Study to Compare Two Forms of Study Medicine Tafamidis in the Blood in Healthy Adults

> **NCT06705569** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 22 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Tafamidis 61 mg free acid tablet (Test)
- **DRUG:** Tafamidis 61 mg free acid capsule (Reference)

## Key facts

- **NCT ID:** NCT06705569
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-20
- **Primary completion:** 2025-04-04
- **Final completion:** 2025-04-04
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2025-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06705569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06705569, "A Study to Compare Two Forms of Study Medicine Tafamidis in the Blood in Healthy Adults". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06705569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*